U.S. Markets close in 2 hrs 47 mins

Hess (HES) Looks Good: Stock Adds 7.8% in Session

Zacks Equity Research

Hess Corporation HES was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $36.43 – $52.61 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen two negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Hess currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Hess Corporation Price

Hess Corporation Price | Hess Corporation Quote

A better-ranked stock in the Oils-Energy sector is CrossAmerica Partners LP CAPL, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is HES going up? Or down? Predict to see what others think: Up or Down

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CrossAmerica Partners LP (CAPL) : Free Stock Analysis Report
 
Hess Corporation (HES) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research